Drug Discovery
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Drug Discovery | Facilities | Industry News
AbCellera to Build Antibody Manufacturing Facility in Canada
130,000-square-foot Vancouver facility aims to accelerate the development of antibody-based therapies for an array of medical conditions.06.23.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Drug Discovery | Industry News
AbSci Acquires Cell Therapy Company Totient
Combination of Totient technology with AbSci's platform provides framework and data to enable in silico targeted drug design.06.17.21
-
Bio News | Breaking News | Drug Development | Drug Discovery | Facilities | Industry News | Information Technology
AbCellera Breaks Ground on Global HQ in Vancouver
380,000 square feet of facilities envisioned as creative tech hub expected to be completed in 2023 and 2024.Tim Wright, Editor, Contract Pharma 05.03.21
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery | Laboratory Testing
Syngene, BMS Extend Long Term Research Alliance until 2030
Extension will include a 40% increase in the number of scientists and the addition of a new 50,000 sq.-ft. dedicated lab space.Kristin Brooks 04.28.21
-
Breaking News | Drug Development | Drug Discovery
KemPharm Receives $10M Milestone for FDA Approval of Azstarys
Is eligible to receive an additional near-term $10 million milestone payment following DEA scheduling of SDX.Charles Sternberg, Assistant Editor 04.22.21
-
Bio News | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News | Information Technology
Hitachi, Axcelead to Develop Next-Gen Biopharmaceuticals
Supporting R&D optimization of next-generation biopharmaceuticals with digital technology and drug discovery platform.Tim Wright, Editor, Contract Pharma 04.07.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
Evotec, Takeda Enter Multi-RNA Target Alliance
To discover and develop small molecule therapeutics for highly attractive targets that are difficult to address via more conventional approaches.Kristin Brooks 03.22.21
-
Bio News | Breaking News | Collaborations & Alliances | CRO News | Drug Development | Drug Discovery | Industry News | R&D
Innoforce and dMed Enter Development Collaboration
Aims to accelerate the development of innovative therapeutics.Tim Wright, Editor, Contract Pharma 03.03.21
-
Breaking News | CRO News | Drug Discovery | Industry News | R&D
Icon to Acquire PRA Health Sciences
Brings together two organizations to create a leading healthcare intelligence and clinical CRO.Charles Sternberg, Assistant Editor 03.01.21
-
Analytical Services | Breaking News | Drug Discovery | Facilities | Industry News | R&D
CatSci Opens New Site in UK
Strengthens analytical capabilities with the opening of a secondary site in Dagenham backed by a $4.2 million investment.Tim Wright, Editor, Contract Pharma 02.25.21
-
Breaking News | Collaborations & Alliances | Drug Discovery | Industry News | Information Technology
CrownBio & JSR Life Sciences Partner with Cambridge Quantum Computing
Will leverage quantum machine learning for novel cancer treatment biomarker discovery.Tim Wright, Editor, Contract Pharma 02.25.21
-
Breaking News | Collaborations & Alliances | CRO News | Drug Discovery | Industry News | R&D
Jubilant Biosys, Yale Form Research Alliance
Aims to accelerate small molecule discovery programs leveraging Jubilant's medicinal chemistry, structural biology, in-vitro and in-vivo pharmacology.02.10.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Drug Discovery | Industry News | Information Technology
Evozyne, Takeda Ink Strategic Protein Design Agreement
Takeda will use Evozyne's evolution-based protein design technology to research and develop proteins for next-gen gene therapies.Kristin Brooks 01.28.21
-
Breaking News | Drug Discovery | Industry News | Preclinical Outsourcing
X-Chem Acquires IntelliSyn and AviSyn
Acquisitions allow the company to offer services for screening, hit validation and lead optimization on existing and new markets.Kristin Brooks 01.26.21
-
Breaking News | Drug Development | Drug Discovery | Industry News
Lilly Completes $1B Acquisition of Prevail
Adds new modality for drug discovery and development and creates a gene therapy program with neuroscience assets.Kristin Brooks 01.22.21
-
Breaking News | Collaborations & Alliances | Drug Discovery
Metrion, LifeArc Extend Neuroscience Alliance
Collaboration extended for another 12 months after successfully progressing into late stage hit-to-lead optimization phase.Contract Pharma Staff 01.18.21
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
Janssen, TenNor Enter NTM Research Pact
To leverage TenNor’s multitargeting drug conjugation platform to discover new therapies to treat nontuberculous mycobacteria diseases.Contract Pharma Staff 01.18.21
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
EVOQ Therapeutics and Amgen Partner
Collaborate on the discovery and development of novel drugs for autoimmune disorders.Contract Pharma Staff 01.13.21
-
Breaking News | Collaborations & Alliances | Drug Discovery | Industry News | R&D
Almac Sciences Secures Support from Invest NI
Accelerates enzyme discovery program.Contract Pharma Staff 01.13.21
-
Breaking News | Collaborations & Alliances | Drug Discovery | Industry News | R&D
Mogrify Enters Research Collaboration with MRC LMB
Research project aims to develop novel protein expression systems via cell reprogramming.Contract Pharma Staff 01.11.21
